PEOPLE

Andrew Fesnak, MD

Assistant Professor of Clinical Pathology and Laboratory Medicine
University of Pennsylvania Perelman School of Medicine

Contact Information3 White Building
Hospital of the University of Pennsylvania
Philadephia, PA 19104
Office: 2158739134

Specialty Division

Transfusion Medicine & Therapeutic Pathology

Education

BA (Molecular Biology), Princeton University, 2005
MD University of Medicine and Dentistry of New Jersey - Robert Wood Johnson School of Medicine, 2011

Specialty Certification

Clinical Pathology, American Board of Pathology, 2014
Laboratory Management, Laboratory Management University, American Society for Clinical Pathology, 2015
Blood Banking / Transfusion Medicine, American Board of Pathology, 2015

Postgraduate Training

Resident, Clinical pathology, Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, 2011-2014
Research fellow, Immunology, Perelman School of Medicine, University of Pennsylvania, 2012-2015
Clinical fellow, Transfusion medicine, Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, 2014-2015
Clinical fellow, Cell therapy, Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, 2015-2016

Awards and Honors

Inductee, Gold Humanism Honor Society, 2011
The Kevin E. Salhany, MD Award for Excellence in Clinical Teaching, Department of Pathology and Laboratory Medicine Penn Medicine, 2016

Memberships and Professional Organizations

International Society for Cellular Therapy, 2011 - Present
College of American Pathologists, 2011 - 2013
AABB, 2011 - Present
American Society of Hematology, 2014 - Present

Web Links


Selected Publications

CAR-T Cell Therapies From the Transfusion Medicine Perspective

Fesnak, A., Lin, C. Y., Siegel, D. L., Maus, M. V., Transfusion Medicine Reviews 30(3): 139-145, 2016

CART Cells

Bhoj V, Fesnak A, AABB Webinar - Novel Therapies and CT Product Development, 2016

Durable Remissions with Control of Cytokine Release Syndrome (Crs) Using T Cells Expressing Cd19 Targeted Chimeric Antigen Receptor (Car) Ctl019 to Treat Relapsed/Refractory (R/R) Acute Lymphoid Leukemia (All)

Levine, B. L., Maude, S., Zheng, Z., Shaw, P., Ambrose, D., Aplenc, R., Barker, C., Barrett, D., Brogdon, J., Callahan, C., Chen, F., Chew, A., Davis, M. M. S., Fesnak, A. D., Finklestein, J., Frey, N., Lacey, S., Lamontagne, A., Lewitt, L., Loew, A., Marcucci, K., Melenhorst, J., Motley, L., Mudambi, M., Nazimuddin, F., O'Rourke, M., Porter, D., Rheingold, S. R., Scholler, J., Tayor, C., White, C., Wood, P., Young, R., Teachey, D. T., June, C., Grupp, S., Cytotherapy 18(6): S14-S15, 2016

Immunotherapy with Autologous Cells

Fesnak, Andrew D., Levine, Bruce L., Reviews in Cell Biology and Molecular Medicine, 2016

Engineered T cells: the promise and challenges of cancer immunotherapy

Fesnak, A. D., June, C. H., Levine, B. L., Nature Reviews Cancer 16(9): 566-581, 2016

Designing a Novel Fellowship in Cellular Therapy

Fesnak, A, AABB Webinar - Novel Therapies and CT Product Development, 2015

HDFN: Hemolytic Disease of the Fetus and Newborn

Judd J, Fesnak A, American Red Cross Biomedical Services Operations, IRL Continuing Education 13(3): , 2015

NKG2D expression by CD8(+) T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT

Karimi, M. A., Bryson, J. L., Richman, L. P., Fesnak, A. D., Leichner, T. M., Satake, A., Vonderheide, R. H., Raulet, D. H., Reshef, R., Kambayashi, T., Blood 125(23): 3655-3663, 2015

Conceptualizing Physician Professionalism

Fesnak, A., Rajput, V., Jama-Journal of the American Medical Association 305(14): 1412-1412, 2011

Conflicts in the ICU: perspectives of administrators and clinicians.

Balasta M, Fesnak A, Rajput V, Yearbook of Critical Care Medicine, 2011